News

Pilot Plant Under Construction to Produce Scaffold Biotech’s Vaccine

Pilot Plant Under Construction to Produce Scaffold Biotech’s Vaccine

Work is being finalized on a pilot GMP plant where Scaffold Biotech will produce batches of its vaccine against bovine ticks. The plant is located next to the startup’s laboratory within the Institut Pasteur de Montevideo. Its inauguration is planned for October, and work is underway to obtain the necessary authorization. The vaccines produced...

read more
Scaffold Biotech Presents Its Vaccine to the Chinese Embassy

Scaffold Biotech Presents Its Vaccine to the Chinese Embassy

Scaffold Biotech, which is developing a vaccine against bovine ticks, presented its work to the Chinese Ambassador to Uruguay, Huang Yazhon, and Counselor Jiang Minghui. The officials visited the Institut Pasteur de Montevideo, where they met with the institute’s leadership and members of the startup. Ticks are a challenge affecting several...

read more
B4-RNA and Guska Move to the Next Stage of Pasaporte Emprendedor

B4-RNA and Guska Move to the Next Stage of Pasaporte Emprendedor

B4-RNA and Guska, two startups supported by LAB+, have been selected for the next stage of Pasaporte Emprendedor. The program, organized by Ingenio Business Incubator (LATU), the National Research and Innovation Agency (ANII), and Endeavor, provides training, mentorship, and key tools to help scale growing startups. After several days of...

read more

Read the first edition of our newsletter here.

(It’s in Spanish, but there’s a translation option at the top right of the menu)

LAB+ in the Media:

Local

Radio Sarandí – Interview with Matías Machado about Scaffold Biotech’s cattle tick vaccine

El País – The five key features of the Uruguayan vaccine that could change the fight against ticks

Radio Sarandí – Carlos Batthyány talks about Lab+, the vaccine developed by Scaffold Biotech, and the drug from Eolo Pharma

InfoNegocios – A Uruguayan startup dedicated to early cancer diagnosis adds a former dLocal member as CEO

Forbes Uruguay – Interview with Carlos Batthyány about LAB+ and the Institut Pasteur de Montevideo

Búsqueda – International call for startups, interview with Carlos Batthyány and Paul Elberse

En Perspectiva – Agustín Correa and Matías Machado, from Scaffold Biotech: Uruguayan company works with protein engineering to reach a ‘new frontier in vaccination’

Modo País (Channel 5) – Guska, created by Pilar Moreno and Gonzalo Moratorio

En Perspectiva – Felipe Trajtenberg, from LoCBio: reprogramming bacteria to treat colorectal cancer

La Diaria – What do the first four start-ups of the LAB+ seek to develop?

Telemundo  (Channel 12) – Scaffold Biotech: more efficient vaccines for animals

En Perspectiva – Director of the Institut Pasteur de Montevideo talks about the LAB+ iniciative and Gonzalo Moratorio explains the science behind the start-up Guska

Subrayado (Channel 10) – LAB+ closed its first financing cycle

Radio Carve – Director of the Institut Pasteur de Montevideo talks about LAB+

La Diaria – Conversations with the first four biotech start-ups funded by LAB+

El País (Business) – Institut Pasteur de Montevideo presented its first four start-ups

Uruguay XXI – Institut Pasteur de Montevideo presented its first four start-ups

Telenoche (Channel 4) – Juan Pablo Tosar talks about the start-up B4-RNA

Ambito – The Institut Pasteur will invest US$25M in Uruguayan start-ups

El Observador – Four start-ups from the Institut Pasteur de Montevideo obtained financing for US$ 5 million: which are they?

Telenoche (Channel 4) – Institut Pasteur de Montevideo presented its LAB+ Company Builder initiative

Montevideo Portal – The Institut Pasteur de Montevideo presents a program to support scientific-technological companies